Royalty Pharma plc (RPRX)

Royalty Pharma Revenue

In the year 2025, Royalty Pharma had annual revenue of $2.38B with 5.06% growth. Royalty Pharma had revenue of $621.99M in the quarter ending December 31, 2025, with 4.78% growth.

• Revenue (ttm): $2.38B
• Revenue Growth: +5.06%
• P/S Ratio: 12.37
• Revenue / Employee: $23,781,930
• Employees: 100
• Market Cap: 29.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.38B	114.61M	5.06%
Dec 31, 2024	2.26B	-90.97M	-3.86%
Dec 31, 2023	2.35B	117.33M	5.24%
Dec 31, 2022	2.24B	-52.24M	-2.28%
Dec 31, 2021	2.29B	167.11M	7.87%
Dec 31, 2020	2.12B	308.10M	16.98%
Dec 31, 2019	1.81B	19.36M	1.08%
Dec 31, 2018	1.79B	196.96M	12.33%
Dec 31, 2017	1.60B	-	-